Shares of Sotera Health (NASDAQ:SHC – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $15.92.
SHC has been the subject of several research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Finally, Barclays reduced their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday, February 28th.
Check Out Our Latest Analysis on Sotera Health
Hedge Funds Weigh In On Sotera Health
Sotera Health Stock Up 0.5 %
Shares of NASDAQ:SHC opened at $11.99 on Wednesday. The company has a market capitalization of $3.40 billion, a PE ratio of 47.96 and a beta of 1.92. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.08. The firm has a 50 day simple moving average of $13.01 and a 200-day simple moving average of $14.21.
Sotera Health Company Profile
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Articles
- Five stocks we like better than Sotera Health
- How to Invest in the Best Canadian Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Most active stocks: Dollar volume vs share volume
- 3 Must-Own Stocks to Build Wealth This Decade
- 3 Dividend Kings To Consider
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.